Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Primary Hyperoxaluria Drug market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Primary Hyperoxaluria Drugmarket, defines the market attractiveness level of Primary Hyperoxaluria Drug market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Primary Hyperoxaluria Drug industry, describes the types of Primary Hyperoxaluria Drug market, the applications of major players and the market size, and deeply analyzes the current situation of the global Primary Hyperoxaluria Drug market and the development prospects and opportunities of Primary Hyperoxaluria Drug industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Primary Hyperoxaluria Drug market in Chapter 13.
By Player:
Allena Pharmaceuticals Inc
Dicerna Pharmaceuticals Inc
OxThera AB
Alnylam Pharmaceuticals Inc
Intellia Therapeutics Inc
By Type:
ALLN-230
DCR-PHXC
ALN-GO1
Others
By End-User:
Hospital
Clinic
Others
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Primary Hyperoxaluria Drug Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Primary Hyperoxaluria Drug Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Primary Hyperoxaluria Drug Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Primary Hyperoxaluria Drug Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Primary Hyperoxaluria Drug Market Analysis and Outlook to 2022
-
7.1 Global Primary Hyperoxaluria Drug Consumption (2017-2022)
-
7.2 United States Primary Hyperoxaluria Drug Consumption (2017-2022)
-
7.3 Europe Primary Hyperoxaluria Drug Consumption (2017-2022)
-
7.4 China Primary Hyperoxaluria Drug Consumption (2017-2022)
-
7.5 Japan Primary Hyperoxaluria Drug Consumption (2017-2022)
-
7.6 India Primary Hyperoxaluria Drug Consumption (2017-2022)
-
7.7 South Korea Primary Hyperoxaluria Drug Consumption (2017-2022)
8 Region and Country-wise Primary Hyperoxaluria Drug Market Analysis and Outlook to 2028
-
8.1 Global Primary Hyperoxaluria Drug Consumption Forecast (2022-2028)
-
8.2 United States Primary Hyperoxaluria Drug Consumption Forecast (2022-2028)
-
8.3 Europe Primary Hyperoxaluria Drug Consumption Forecast (2022-2028)
-
8.4 China Primary Hyperoxaluria Drug Consumption Forecast (2022-2028)
-
8.5 Japan Primary Hyperoxaluria Drug Consumption Forecast (2022-2028)
-
8.6 India Primary Hyperoxaluria Drug Consumption Forecast (2022-2028)
-
8.7 South Korea Primary Hyperoxaluria Drug Consumption Forecast (2022-2028)
9 Global Primary Hyperoxaluria Drug Market Outlook by Types and Applications to 2022
-
9.1 Global Primary Hyperoxaluria Drug Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global ALLN-230 Consumption and Growth Rate (2017-2022)
-
9.1.2 Global DCR-PHXC Consumption and Growth Rate (2017-2022)
-
9.1.3 Global ALN-GO1 Consumption and Growth Rate (2017-2022)
-
9.1.4 Global Others Consumption and Growth Rate (2017-2022)
-
9.2 Global Primary Hyperoxaluria Drug Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Hospital Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Clinic Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Others Consumption and Growth Rate (2017-2022)
10 Global Primary Hyperoxaluria Drug Market Outlook by Types and Applications to 2028
-
10.1 Global Primary Hyperoxaluria Drug Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global ALLN-230 Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global DCR-PHXC Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global ALN-GO1 Consumption Forecast and Growth Rate (2022-2028)
-
10.1.4 Global Others Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Primary Hyperoxaluria Drug Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Hospital Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Clinic Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Others Consumption Forecast and Growth Rate (2022-2028)
11 Global Primary Hyperoxaluria Drug Import and Export Analysis (Top 5 Countries)
-
11.1 Global Primary Hyperoxaluria Drug Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Primary Hyperoxaluria Drug Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Primary Hyperoxaluria Drug Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Primary Hyperoxaluria Drug Market Competitive Analysis
-
14.1 Allena Pharmaceuticals Inc
-
14.1.1 Allena Pharmaceuticals Inc Company Details
-
14.1.2 Allena Pharmaceuticals Inc Primary Hyperoxaluria Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Allena Pharmaceuticals Inc Primary Hyperoxaluria Drug Product and Service
-
14.2 Dicerna Pharmaceuticals Inc
-
14.2.1 Dicerna Pharmaceuticals Inc Company Details
-
14.2.2 Dicerna Pharmaceuticals Inc Primary Hyperoxaluria Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Dicerna Pharmaceuticals Inc Primary Hyperoxaluria Drug Product and Service
-
14.3 OxThera AB
-
14.3.1 OxThera AB Company Details
-
14.3.2 OxThera AB Primary Hyperoxaluria Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 OxThera AB Primary Hyperoxaluria Drug Product and Service
-
14.4 Alnylam Pharmaceuticals Inc
-
14.4.1 Alnylam Pharmaceuticals Inc Company Details
-
14.4.2 Alnylam Pharmaceuticals Inc Primary Hyperoxaluria Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Alnylam Pharmaceuticals Inc Primary Hyperoxaluria Drug Product and Service
-
14.5 Intellia Therapeutics Inc
-
14.5.1 Intellia Therapeutics Inc Company Details
-
14.5.2 Intellia Therapeutics Inc Primary Hyperoxaluria Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Intellia Therapeutics Inc Primary Hyperoxaluria Drug Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Primary Hyperoxaluria Drug
-
Figure Primary Hyperoxaluria Drug Picture
-
Table Global Primary Hyperoxaluria Drug Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Primary Hyperoxaluria Drug Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Primary Hyperoxaluria Drug Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Primary Hyperoxaluria Drug Consumption by Country (2017-2022)
-
Figure United States Primary Hyperoxaluria Drug Consumption and Growth Rate (2017-2022)
-
Table Europe Primary Hyperoxaluria Drug Consumption and Growth Rate (2017-2022)
-
Figure China Primary Hyperoxaluria Drug Consumption and Growth Rate (2017-2022)
-
Figure Japan Primary Hyperoxaluria Drug Consumption and Growth Rate (2017-2022)
-
Figure India Primary Hyperoxaluria Drug Consumption and Growth Rate (2017-2022)
-
Figure South Korea Primary Hyperoxaluria Drug Consumption and Growth Rate (2017-2022)
-
Figure Global Primary Hyperoxaluria Drug Consumption Forecast by Country (2022-2028)
-
Figure United States Primary Hyperoxaluria Drug Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Primary Hyperoxaluria Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Primary Hyperoxaluria Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Primary Hyperoxaluria Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Primary Hyperoxaluria Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Primary Hyperoxaluria Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global ALLN-230 Consumption and Growth Rate (2017-2022)
-
Figure Global DCR-PHXC Consumption and Growth Rate (2017-2022)
-
Figure Global ALN-GO1 Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global Hospital Consumption and Growth Rate (2017-2022)
-
Figure Global Clinic Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global ALLN-230 Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global DCR-PHXC Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global ALN-GO1 Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hospital Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Clinic Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Primary Hyperoxaluria Drug Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Primary Hyperoxaluria Drug Export by Region (Top 5 Countries) (2017-2028)
-
Table Allena Pharmaceuticals Inc (Foundation Year, Company Profile and etc.)
-
Table Allena Pharmaceuticals Inc Primary Hyperoxaluria Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Allena Pharmaceuticals Inc Primary Hyperoxaluria Drug Product and Service
-
Table Dicerna Pharmaceuticals Inc (Foundation Year, Company Profile and etc.)
-
Table Dicerna Pharmaceuticals Inc Primary Hyperoxaluria Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Dicerna Pharmaceuticals Inc Primary Hyperoxaluria Drug Product and Service
-
Table OxThera AB (Foundation Year, Company Profile and etc.)
-
Table OxThera AB Primary Hyperoxaluria Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table OxThera AB Primary Hyperoxaluria Drug Product and Service
-
Table Alnylam Pharmaceuticals Inc (Foundation Year, Company Profile and etc.)
-
Table Alnylam Pharmaceuticals Inc Primary Hyperoxaluria Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Alnylam Pharmaceuticals Inc Primary Hyperoxaluria Drug Product and Service
-
Table Intellia Therapeutics Inc (Foundation Year, Company Profile and etc.)
-
Table Intellia Therapeutics Inc Primary Hyperoxaluria Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Intellia Therapeutics Inc Primary Hyperoxaluria Drug Product and Service
-
